XRCC2 and glioma: Moreover, to understand how XRCC2 participates in the malignant progression of glioma and it actually reduces the survival rate of patients, we performed GSEA analysis on three different datasets and found that the signaling pathways of cell cycle, DNA replication, homologous recombination, and mismatch repair were significantly enriched in all three data sets.